Overview of Flazol
| Property | Description |
|---|---|
| Active Ingredient | Metronidazole |
| Pharmacological Class | Antimicrobial Agent (Nitroimidazole) |
| Form | Tablet, Suspension, Intravenous Solution, Topical Cream/Gel |
| Primary Action Type | Antibiotic and Antiprotozoal |
| Origin | Synthetic Compound |
Flazol is a prescription-only synthetic pharmaceutical preparation whose active substance is Metronidazole. Its core identity is defined by its membership in the nitroimidazole class of antimicrobials, functioning distinctly as both a targeted antibiotic and an effective antiprotozoal agent.
What Type of Medicine is Flazol and What is its Classification?
Flazol is classified as a dual-action antimicrobial, specifically a synthetic organic compound designed to target two distinct types of pathogens: obligate anaerobic bacteria and certain protozoal parasites. The active ingredient, Metronidazole, is a synthetic derivative that exhibits selective toxicity by becoming chemically activated inside the susceptible microbes themselves, a mechanism critical to its efficacy. Metronidazole is recognized as a primary agent against certain protozoal diseases, used in the treatment of parasitic infections. This application highlights the drug's ability to eliminate these specific parasitic targets.
Composition, Origin, and Available Forms
The primary component of Flazol is the chemical entity Metronidazole, a compound originating from the synthetic nitroimidazole structure. This medicine is provided in multiple pharmaceutical preparations to facilitate different routes of administration. These forms include systemic options such as oral tablets and oral suspension, as well as an intravenous (IV) solution for parenteral administration in severe cases. A distinctive feature of the Flazol formulation family is the provision of an oral suspension, often used for pediatric or non-swallowing adult patient groups. Furthermore, localized treatments are supplied as topical creams or gels, utilizing an appropriate base or vehicle for direct application.
The General Therapeutic Purpose of Flazol
The general therapeutic purpose of Flazol is the eradication of infection caused by microorganisms that are susceptible to the nitroimidazole mechanism. Flazol's highly focused action is beneficial for managing conditions traced to obligate anaerobic bacteria and specific protozoal parasites. For instance, it is commonly used for prophylaxis against postoperative infections, demonstrating its role beyond treating active disease. By disrupting the nucleic acid synthesis of these pathogens, Flazol helps eliminate the microbial source of the infection, which is its overall function in therapeutic management.
Regulatory References
